Vanadom Side Effects

Generic name: carisoprodol

Note: This document contains side effect information about carisoprodol. Some of the dosage forms listed on this page may not apply to the brand name Vanadom.

Some side effects of Vanadom may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

For the Consumer

Applies to carisoprodol: compounding powder, oral tablet

Get emergency medical help if you have any of these signs of an allergic reaction while taking carisoprodol (the active ingredient contained in Vanadom) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using carisoprodol and call your doctor at once if you have any of these serious side effects:

  • paralysis (loss of feeling);

  • extreme weakness or lack of coordination;

  • feeling light-headed, fainting;

  • fast heartbeat;

  • seizure (convulsions);

  • vision loss; or

  • agitation, confusion.

Less serious side effects of carisoprodol may include:

  • drowsiness, dizziness, tremor;

  • headache;

  • depression, feeling irritable;

  • blurred vision;

  • sleep problems (insomnia); or

  • nausea, vomiting, hiccups, upset stomach.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect.

For Healthcare Professionals

Applies to carisoprodol: compounding powder, oral tablet

Nervous system

Nervous system side effects are common and include drowsiness and sedation most often. There have been postmarketing reports of motor vehicle accidents associated with the use of carisoprodol (the active ingredient contained in Vanadom) Dizziness, headache, tremor, agitation, insomnia, syncope and ataxia have also been reported.

Central respiratory depression may occur, particularly at high doses.

Other

Psychologic dependence and abuse of carisoprodol (the active ingredient contained in Vanadom) (often in combination with alcohol and other CNS depressants) have been reported.

Withdrawal symptoms after abrupt cessation of carisoprodol have been reported and may be due to dependency on the meprobamate metabolite. Such symptoms include abdominal pain, agitation, tremor, restlessness, anxiety, depression, insomnia, nausea, and sweating. Seizures have been reported rarely.

Hypersensitivity

Hypersensitivity effects include rash, pruritus and erythema multiforme. Asthma, fever, hypotension and anaphylaxis have been reported rarely.

Gastrointestinal

Gastrointestinal symptoms include nausea, vomiting, hiccups and epigastric distress.

Cardiovascular

Cardiovascular effects include tachycardia, hypotension, postural hypotension, and facial flushing.

Oncologic

Oncologic side effects have included mutagenicity and clastogenicity reported from in vitro animal cell assays.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Help us improve Drugs.com: Take our quick 1 question survey

Close
(web1)